F10 health effect, clinical code: code e2402 utilized; appropriate term ¿migration¿ is not available.(note that although migration is an available medical device problem code, in this report¿s context, the migration does not reflect a problem with the functionality or delivery of therapy of the device.Therefore, a device problem code does not adequately capture the patient¿s adverse event.Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was initially reported that the patient was scheduled for a full revision.Follow-up with the patient's physician found that upon interrogation, low impedance was seen.An x-ray showed the lead had crossed over/ migrated.During the battery replacement surgery, there were many areas of abraded insulation of the lead in the area of crossover, so a full revision was performed.The patient's physician later reported that the cause of the lead migration is not related to patient manipulation, trauma, or not being secured properly during implant, but to "other." the cause of the abraded lead insulation is related to the age of the lead.The explanted devices were discarded and are not available for return to the manufacturer.No other relevant information has been received to date.
|